Does hydralazine have a significant impact on heart rate (HR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Impact of Hydralazine on Heart Rate

Hydralazine typically causes a reflex increase in heart rate due to its arterial vasodilating effect and the resulting sympathetic nervous system activation. 1, 2

Mechanism of Action and Cardiovascular Effects

  • Hydralazine is a direct-acting arterial vasodilator that works by relaxing vascular smooth muscle, primarily affecting arterial blood vessels with minimal effect on venous tone 1
  • The peripheral vasodilating effect results in decreased arterial blood pressure (diastolic more than systolic) and decreased peripheral vascular resistance 1
  • This vasodilation triggers a compensatory reflex increase in heart rate, stroke volume, and cardiac output 1, 2
  • The preferential dilation of arterioles compared to veins minimizes postural hypotension while promoting increased cardiac output 1

Magnitude of Heart Rate Effect

  • Studies have shown that hydralazine can increase heart rate by approximately 11-17 beats per minute following administration 3, 2
  • In patients with symptomatic sinus bradycardia, hydralazine has been shown to produce an increase of 28% ± 15% in heart rate 4
  • The chronotropic effect is primarily mediated through the autonomic nervous system, as demonstrated by studies showing minimal heart rate changes after autonomic blockade 4

Mechanism of Heart Rate Increase

  • The heart rate increase is primarily a reflex response to the drop in blood pressure caused by hydralazine's vasodilatory effects 1, 2
  • This reflex is mediated through:
    • Increased sympathetic nervous system activity 2
    • Elevated circulating norepinephrine levels (shown to increase from 159 to 294 pg/ml in one study) 2
    • Decreased sinoatrial conduction time (by approximately 32% ± 32%) 4

Clinical Considerations

  • The heart rate effect is dose-dependent and may be more pronounced at higher doses 2
  • When used in hypertension management, the heart rate increase may be a limiting factor in some patients 3
  • In patients with pulmonary hypertension, the reflex tachycardia (approximately 11 beats per minute increase) combined with systemic hypotension can lead to adverse outcomes 3
  • The chronotropic effect may be less pronounced when hydralazine is combined with medications that blunt sympathetic response, such as beta-blockers 5

Duration of Effect

  • The heart rate effects typically parallel the blood pressure effects of hydralazine 6
  • After discontinuation of hydralazine, the time for physiological parameters to return to baseline can vary from 30 to 140 hours 6
  • The heart rate increase is sustained throughout the duration of the drug's action, with studies showing elevation at 6 hours post-administration 2

Special Considerations

  • In heart failure patients, hydralazine is typically used in combination with isosorbide dinitrate rather than as monotherapy 7, 5
  • This combination provides complementary effects with hydralazine causing arterial vasodilation and isosorbide dinitrate causing venous vasodilation 5
  • The heart rate effect may be less clinically significant in this combination therapy context 7

In conclusion, hydralazine has a significant impact on heart rate through reflex sympathetic activation, which is an expected physiological response to its vasodilatory effects. This should be considered when prescribing the medication, particularly in patients with conditions where tachycardia might be detrimental.

References

Research

Hemodynamic effects of oxdralazine and hydralazine in hypertension.

Clinical pharmacology and therapeutics, 1980

Guideline

Role of Hydralazine in Myocardial Infarction (MI)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Duration of hydralazine action in hypertension.

Clinical pharmacology and therapeutics, 1975

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.